Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dewi Vernerey

Showing results (11-20 of 155) with videos related to

Pageof 16
Sort By:
Expert Review of Anticancer Therapy|June 2, 2015
Health-related quality-of-life as co-primary endpoint in randomized clinical trials in oncologyFrédéric Fiteni, Alhousseiny Pam, Amélie Anota, et al.
Inflammatory Bowel Diseases|September 30, 2023
KONO-S Anastomosis Is Not Superior to Conventional Anastomosis for the Reduction of Postoperative Endoscopic Recurrence in Crohn's DiseaseGaëlle Tyrode, Zaher Lakkis, Dewi Vernerey, et al.
BMC Cancer|March 5, 2020
Correction to: Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study)Lilian Schwarz, Dewi Vernerey, Jean-Baptiste Bachet, et al.
The Annals of Thoracic Surgery|January 18, 2015
Neutrophil gelatinase-associated lipocalin as early predictor of acute kidney injury after cardiac surgery in adults with chronic kidney failureAndrea Perrotti, Guillaume Miltgen, Albin Chevet-Noel, et al.
La Revue Du Praticien|February 23, 2026
[Breast cancer: an example of changing practices that take age-related factors into account. About the ASTER 70s study]Étienne Brain, Florence Rollot-Trad, Godelieve Rochette de Lempdes, et al.
The Oncologist|July 16, 2024
A novel risk classification model integrating CEA, ctDNA, and pTN stage for stage 3 colon cancer: a post hoc analysis of the IDEA-France trialThomas Samaille, Antoine Falcoz, Romain Cohen, et al.
BMC Cancer|July 26, 2018
Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study)Lilian Schwarz, Dewi Vernerey, Jean-Baptiste Bachet, et al.
Neuro-Oncology Practice|April 26, 2021
Quality of patient-reported outcome reporting according to the CONSORT statement in randomized controlled trials with glioblastoma patientsLouis Garnier, Emilie Charton, Antoine Falcoz, et al.
Radiation Oncology (London, England)|July 15, 2024
A comparison of target volumes drawn on arterial and venous phase scans during radiation therapy planning for patients with pancreatic cancer: the PANCRINJ studyFabien Zaidi, Paul Calame, Cédric Chevalier, et al.
Annals of Surgical Oncology|October 24, 2019
Fong's Score in the Era of Modern Perioperative Chemotherapy for Metastatic Colorectal Cancer: A Post Hoc Analysis of the GERCOR-MIROX Phase III TrialSamira Makhloufi, Anthony Turpin, Mehdi El Amrani, et al.
Pageof 16

Showing results (11-20 of 155) with videos related to

Sort By:
Pageof 16
Expert Review of Anticancer Therapy|June 2, 2015
Health-related quality-of-life as co-primary endpoint in randomized clinical trials in oncologyFrédéric Fiteni, Alhousseiny Pam, Amélie Anota, et al.
Inflammatory Bowel Diseases|September 30, 2023
KONO-S Anastomosis Is Not Superior to Conventional Anastomosis for the Reduction of Postoperative Endoscopic Recurrence in Crohn's DiseaseGaëlle Tyrode, Zaher Lakkis, Dewi Vernerey, et al.
BMC Cancer|March 5, 2020
Correction to: Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study)Lilian Schwarz, Dewi Vernerey, Jean-Baptiste Bachet, et al.
The Annals of Thoracic Surgery|January 18, 2015
Neutrophil gelatinase-associated lipocalin as early predictor of acute kidney injury after cardiac surgery in adults with chronic kidney failureAndrea Perrotti, Guillaume Miltgen, Albin Chevet-Noel, et al.
La Revue Du Praticien|February 23, 2026
[Breast cancer: an example of changing practices that take age-related factors into account. About the ASTER 70s study]Étienne Brain, Florence Rollot-Trad, Godelieve Rochette de Lempdes, et al.
The Oncologist|July 16, 2024
A novel risk classification model integrating CEA, ctDNA, and pTN stage for stage 3 colon cancer: a post hoc analysis of the IDEA-France trialThomas Samaille, Antoine Falcoz, Romain Cohen, et al.
BMC Cancer|July 26, 2018
Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study)Lilian Schwarz, Dewi Vernerey, Jean-Baptiste Bachet, et al.
Neuro-Oncology Practice|April 26, 2021
Quality of patient-reported outcome reporting according to the CONSORT statement in randomized controlled trials with glioblastoma patientsLouis Garnier, Emilie Charton, Antoine Falcoz, et al.
Radiation Oncology (London, England)|July 15, 2024
A comparison of target volumes drawn on arterial and venous phase scans during radiation therapy planning for patients with pancreatic cancer: the PANCRINJ studyFabien Zaidi, Paul Calame, Cédric Chevalier, et al.
Annals of Surgical Oncology|October 24, 2019
Fong's Score in the Era of Modern Perioperative Chemotherapy for Metastatic Colorectal Cancer: A Post Hoc Analysis of the GERCOR-MIROX Phase III TrialSamira Makhloufi, Anthony Turpin, Mehdi El Amrani, et al.
Pageof 16